Nidhi P. Bhagat, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 9500 Stockdale Hwy Ste 203, Bakersfield, CA 93311 Phone: 661-587-8110 Fax: 661-587-8220 |
Mr. Francis Marlo Collantes Simeon, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 2615 Chester Ave, Bakersfield, CA 93301 Phone: 661-869-6227 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
In an early-stage breakthrough, a team of Northwestern University scientists has developed a new family of compounds that could slow the progression of Parkinson's disease.
There is a wide gender divide when it comes to how men and women are prescribed and adhere to their medications. According to a new study, while women use more prescription drugs than men, they are less likely to be prescribed drugs according to clinical guidelines and are not as good about adhering to the medications they are prescribed.
Pulmonary embolism - the sudden blockage of an artery in the lung - is estimated to cause over 100,000 deaths each year in the U.S. Although thrombolytics, or "clot-buster" drugs, are currently reserved to treat only the most severe cases of pulmonary embolism, new data suggest that when used at lower doses, these drugs are also safe and effective for more common, moderate cases of pulmonary embolism, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
› Verified 2 days ago